TL;DR
This study reveals that Granulocyte Colony-Stimulating Factor (G-CSF), while potentially beneficial for heart repair, actually worsens atherosclerosis in rabbits fed a high-fat diet. G-CSF exacerbates lipid abnormalities and endothelial cell damage, suggesting it could be a risk factor for atherosclerosis, particularly in individuals with hyperlipidemia.
What Problem Does This Paper Address?
G-CSF is known to promote stem cell mobilization and has shown promise in repairing heart damage after myocardial infarction. However, its role in atherosclerosis, a chronic inflammatory disease of the arteries, has been unclear, with some clinical studies showing conflicting results. Given that atherosclerosis is a major contributor to cardiovascular disease and often co-exists with hyperlipidemia, understanding G-CSF's impact in this context is crucial for its safe and effective clinical application. This paper aims to clarify whether G-CSF's effects on atherosclerosis differ in the presence or absence of hyperlipidemia.
Methods
The researchers utilized a rabbit model of atherosclerosis. Six-month-old male New Zealand white rabbits were divided into four groups:
- Normal diet + Vehicle: Control group on a standard diet.
- Normal diet + G-CSF: Standard diet with G-CSF treatment.
- High-fat diet + Vehicle: Atherosclerosis-prone group on a diet with 1% cholesterol and 5% lard.
- High-fat diet + G-CSF: Atherosclerosis-prone group with G-CSF treatment.
The high-fat diet was administered for 10 weeks. G-CSF was injected subcutaneously for the first 3 weeks. Key analyses included:
- Morphological Analysis: Sudan III staining to quantify atherosclerotic lesion area in the thoracic aorta. Hematoxylin-eosin (HE) staining and electron microscopy (scanning and transmission) to examine ultrastructural changes in endothelial cells.
- Biochemical Analysis: Measurement of plasma lipid levels (Total Cholesterol - TC, Triglycerides - TG, LDL-C, HDL-C) and White Blood Cell (WBC) counts.
- In Vitro Studies: Isolation and culture of aortic endothelial cells (ECs) to assess the effects of G-CSF and oxidized LDL (OX-LDL) on apoptosis and gene expression.
- Apoptosis Analysis: TUNEL assay on both aortic tissue and cultured ECs to quantify cell death.
- Gene Expression Analysis: Real-time RT-PCR to measure the mRNA levels of endothelin-1 (ET-1) and endothelial nitric oxide synthase (eNOS).
Datasets
Not discussed in the paper. The study utilized experimental animal models and in vitro cell cultures.
Key Insights and Ideas
- G-CSF as an Atherosclerosis Promoter in Hyperlipidemia: The most striking finding is that G-CSF, when combined with a high-fat diet, significantly worsens atherosclerosis. This directly contradicts its potential role in cardiovascular repair and highlights a critical context-dependent effect.
- Dual Impact on Lipids and Endothelium: G-CSF not only increased plasma levels of TC and LDL-C in the early stages of the high-fat diet but also severely damaged the arterial endothelium, promoting apoptosis. This suggests a multi-pronged attack on the vascular system.
- ET-1/eNOS Imbalance: The study identified a key molecular mechanism: G-CSF promoted the expression of ET-1 (a vasoconstrictor and pro-atherogenic molecule) and decreased the expression of eNOS (which produces protective nitric oxide). This imbalance in the ET-1/eNOS system appears to be central to G-CSF's detrimental effects on endothelial function.
- Context Matters for G-CSF: The paper strongly suggests that the beneficial effects of G-CSF seen in some cardiac repair studies might be masked or reversed in the presence of hyperlipidemia, a common comorbidity in cardiovascular disease.
Key Results
- Increased Lesion Area: G-CSF treatment in high-fat diet rabbits led to a significant increase in atherosclerotic lesion area in the thoracic aorta compared to high-fat diet rabbits without G-CSF.
- Altered Lipid Profiles: G-CSF accelerated the increase in plasma TC and LDL-C in the early phase of the high-fat diet, though it didn't significantly alter peak levels. TG and HDL-C levels were unaffected by G-CSF in the high-fat diet group.
- Endothelial Cell Damage: Electron microscopy revealed that G-CSF significantly aggravated endothelial cell damage, deformation, missing cells, and apoptosis in high-fat diet rabbits.
- Enhanced Apoptosis: TUNEL analysis confirmed that G-CSF significantly increased the number of apoptotic endothelial cells in the thoracic aortae of high-fat diet rabbits and in cultured ECs treated with OX-LDL.
- ET-1/eNOS Dysregulation: G-CSF treatment in high-fat diet rabbits resulted in increased ET-1 mRNA expression and decreased eNOS mRNA expression in thoracic aortae and cultured ECs.
Limitations and Future Work
- Dosing Schedule: The study used a more frequent dosing schedule (15 doses over 3 weeks) than typically seen in human clinical trials. While the doses were similar, the frequency might influence the observed effects.
- Limited Exploration of Mechanisms: The authors acknowledge that they did not explore other potential mechanisms by which G-CSF might influence atherosclerosis.
- Future Directions: The authors emphasize the need for randomized clinical trials to evaluate the feasibility and safety of G-CSF on coronary artery diseases, particularly in patients with hyperlipidemia. Further research could investigate the precise mechanisms of G-CSF's interaction with the ET-1/eNOS system and explore alternative G-CSF administration strategies or combinations with other therapies.
Summary updated